Literature DB >> 15893592

Robustness of gene expression profiling in glioma specimen samplings and derived cell lines.

Ruty Mehrian Shai1, Juergen K V Reichardt, Hsu Ya-Hsuan, Thomas J Kremen, Linda M Liau, Timothy F Cloughesy, Paul S Mischel, Stanley F Nelson.   

Abstract

One of the most promising applications of microarrays is class distinction through gene expression profiling as a diagnostic tool. However, as there is apparent spatial heterogeneity in the morphology of cancer cells within a tumor, it is unclear if tumor sampling can be applied and yield consistent signals. In this report, we examined six brain tumors, four glioblastoma, and two oligodendroglioma biopsies. The six brain tumor tissues from two distinct different classes were dissected in four distinct areas and gene expression was profiled using microarrays. We used hierarchical clustering to compare the variability of gene expression profiles between spatially distinct biopsies of the same tumor as compared to the variability between tumors of the same histologic group. We conclude that, in general, repeat spatially distinct samples are not needed for microarray experiments and the gene expression signatures are robust across the tumor. Predominantly, variation was much greater between samples from different patients than from the multiple samplings of given tumor. Further, we compared biopsy expression profiles to the cell lines derived from those tissues. In general, the tumor cell lines vary greatly from the parental tissues and cluster more strongly with each other than the parental tissue. We select and examine the set of genes altered in expression to allow adaptation to cell culture.

Entities:  

Mesh:

Year:  2005        PMID: 15893592     DOI: 10.1016/j.molbrainres.2005.01.017

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Gene expression in oligodendroglial tumors.

Authors:  Elisabeth J Shaw; Brian Haylock; David Husband; Daniel du Plessis; D Ross Sibson; Peter C Warnke; Carol Walker
Journal:  Cell Oncol (Dordr)       Date:  2011-05-31       Impact factor: 6.730

3.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

Authors:  Isaac Marin-Valencia; Chendong Yang; Tomoyuki Mashimo; Steve Cho; Hyeonman Baek; Xiao-Li Yang; Kartik N Rajagopalan; Melissa Maddie; Vamsidhara Vemireddy; Zhenze Zhao; Ling Cai; Levi Good; Benjamin P Tu; Kimmo J Hatanpaa; Bruce E Mickey; José M Matés; Juan M Pascual; Elizabeth A Maher; Craig R Malloy; Ralph J Deberardinis; Robert M Bachoo
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

Review 4.  The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.

Authors:  James T Rutka; Paul Kongkham; Paul Northcott; Carlos Carlotti; Mustafa Guduk; Hirokatsu Osawa; Orlando Moreno; Ho Jun Seol; Andres Restrepo; Adrienne Weeks; Shoichi Nagai; Christian Smith
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 5.  Preclinical models in radiation oncology.

Authors:  Jenna Kahn; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-12-27       Impact factor: 3.481

6.  BTECH: a platform to integrate genomic, transcriptomic and epigenomic alterations in brain tumors.

Authors:  Min Wang; Hehuang Xie; Wendy Stellpflug; Veena Rajaram; Maria de Fatima Bonaldo; Stewart Goldman; Tadanori Tomita; Marcelo Bento Soares
Journal:  Neuroinformatics       Date:  2011-03

7.  Comparison of transcriptional responses in liver tissue and primary hepatocyte cell cultures after exposure to hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine.

Authors:  Edward J Perkins; Wenjun Bao; Xin Guan; Choo-Yaw Ang; Russell D Wolfinger; Tzu-Ming Chu; Sharon A Meyer; Laura S Inouye
Journal:  BMC Bioinformatics       Date:  2006-12-12       Impact factor: 3.169

8.  Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.

Authors:  Monika Witusik-Perkowska; Magdalena Zakrzewska; Malgorzata Szybka; Wielislaw Papierz; Dariusz J Jaskolski; Pawel P Liberski; Beata Sikorska
Journal:  Cancer Cell Int       Date:  2014-08-22       Impact factor: 5.722

9.  Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.

Authors:  Matthew J Munro; Lifeng Peng; Susrutha K Wickremesekera; Swee T Tan
Journal:  PLoS One       Date:  2020-05-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.